Toggle Main Menu Toggle Search

Open Access padlockePrints

Macrocyclic Peptide Probes for Immunomodulatory Protein CD59: Potent Modulators of Bacterial Toxin Activity and Antibody-Dependent Cytotoxicity

Lookup NU author(s): Dr Tom McAllisterORCiD, Professor Akane Kawamura

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Angewandte Chemie International Edition published by Wiley-VCH GmbH. CD59 is an immunomodulatory cell surface receptor associated with human disease. Despite its importance in complement regulation and bacterial pathogenesis, CD59 remains a challenging therapeutic target. Research to date has focused on antibody or protein-based strategies. Here we present a new approach to target CD59 using macrocyclic peptides with low nanomolar affinity for CD59. Through X-ray crystallographic studies and structure-activity relationship (SAR) studies, we identify key interactions that are essential for binding and activity. We find that the macrocyclic peptide CP-06 adopts a beta-hairpin structure and binds CD59 through an intermolecular beta-sheet, mimicking protein–protein interactions of biologically relevant CD59 interaction partners. We create dimeric and lipidated macrocyclic peptide conjugates as enhanced cell-active CD59 inhibitors and show that these probes can be used to modulate both complement-mediated killing of human cells and lytic activity of bacterial virulence factors. Together, our data provide a starting point for future development of macrocyclic peptides to target CD59 activity in diverse cellular contexts.


Publication metadata

Author(s): Bickel JK, Ahmed AIS, Pidd AB, Morgan RM, McAllister TE, Horrell S, Couves EC, Nagaraj H, Bartlett EJ, El Omari K, Kawamura A, Bubeck D, Tate EW

Publication type: Article

Publication status: Published

Journal: Angewandte Chemie - International Edition

Year: 2025

Pages: Epub ahead of print

Online publication date: 24/04/2025

Acceptance date: 23/04/2025

Date deposited: 13/05/2025

ISSN (print): 1433-7851

ISSN (electronic): 1521-3773

Publisher: John Wiley and Sons Inc.

URL: https://doi.org/10.1002/anie.202422673

DOI: 10.1002/anie.202422673

Data Access Statement: The data that support the findings of this study are available in the supplementary material of this article.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
CRUK Convergence Science Centre at Imperial College London (C24523/A26234)
CRUK Programme Award (DRCNPGNov21∖100001 and C29637/A20183)
Engineering and Physical Sciences Research Council (EPSRC) through the Institute of Chemical Biology (EP/L015498/1)
EPSRC Doctoral Training Program grant (EP/L015498/1)
EPSRC Impact Acceleration Account (EP/R511547/1)
EPSRC Centre for Doctoral Training: Chemical Biology: Physical Sciences Innovation (EP/L015498/1)
EPSRC Doctoral Prize Fellowship
European Union Horizon 2020 research and innovation programme (grant agreement numbers 864751 and 101003111)
Islamic Development Bank
NIHR Imperial Biomedical Research Centre (BRC) Award (RDF01)

Share